MAGNESIUM for Electrolyte substitution therapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where MAGNESIUM was used for Electrolyte substitution therapy.
Most Reported Side Effects for MAGNESIUM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 2,160 | 22.2% | 605 | 1,343 |
| Off label use | 1,502 | 15.4% | 589 | 1,115 |
| Maternal exposure during pregnancy | 1,227 | 12.6% | 484 | 628 |
| Pain | 1,098 | 11.3% | 510 | 837 |
| Nausea | 1,084 | 11.1% | 496 | 840 |
| Dyspnoea | 961 | 9.9% | 487 | 764 |
| Product use in unapproved indication | 949 | 9.7% | 496 | 578 |
| Condition aggravated | 926 | 9.5% | 519 | 747 |
| Vomiting | 912 | 9.4% | 509 | 645 |
| Diarrhoea | 900 | 9.2% | 417 | 554 |
| Foetal exposure during pregnancy | 876 | 9.0% | 81 | 220 |
| Headache | 820 | 8.4% | 356 | 676 |
| Infusion related reaction | 814 | 8.4% | 484 | 731 |
| Rash | 808 | 8.3% | 554 | 689 |
| Exposure during pregnancy | 794 | 8.2% | 244 | 396 |
Other Indications for MAGNESIUM
Product used for unknown indication (4,253)
Constipation (648)
Foetal exposure during pregnancy (327)
Pre-eclampsia (283)
Parenteral nutrition (243)
Nervous system disorder prophylaxis (212)
Prophylaxis (128)
Hypomagnesaemia (112)
Status epilepticus (107)
Ventricular tachycardia (93)